Skip to main content
Equibles
CYDX logo

CYDX · CYduct Diagnostics, Inc.

Track CYDX — free

Use CYDX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CYDX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.91 At close · Nov 9
Rebalance outlook locked
Market Cap
$11.66M
Shares
12.78M
Volume · Nov 9 134 Avg daily vol (7 sessions) 2157

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.91 Open$0.91 Day$0.91–0.91 Available close range$0.40–2.84 Avg vol 30d6K Short int100 · 0.0% of shares · 4.8d Short vol100% DataJan 2020–Nov 2026

The closing range uses available history since Jan 12, 2026; less than a full year is stored.

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+348.9%
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +22%
above
Price vs 50-day avg −17%
below
RSI (14) 46
neutral
MACD trend Negative
52-week position 21%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +8%
trailing
6-month return +27%
trailing
YTD return +349%
this year
Relative strength +24%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of shares out · ▬ 0.0% MoM · 4.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 2760%
annualized · 1-yr
Max drawdown −96%
past year
ATR 38.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+22% Bullish
Price vs 50-day avg
−17% Bearish
RSI (14)
46 Neutral
MACD trend
Negative Bearish
52-week position
21% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of shares out · ▬ 0.0% MoM · 4.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $0 Now $1 · 21% Range high $3
vs 200-day avg +22% vs 50-day avg -17%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CYDX
CYduct Diagnostics, Inc.
this stock
$11.66M — — — 0.0%
ABT
Abbott Laboratories
 $185.75B -14.4% +5.7% 40.0 1.1%
MDT
Medtronic plc
 $129.18B +5.1% +8.4% 24.9 1.8%
SYK
Stryker Corp
 $118.92B -11.1% +11.2% 33.3 1.7%
BSX
Boston Scientific Corp
 $64.07B -53.6% +12.5% 18.7 2.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest
Shares short
100
Days to cover
4.8d
Change
0 sh
View
Short Volume
Short vol %
100%
As of
Oct 16, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$1
As of
Apr 15, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 28, 2026
Off-exch Lit
View
Filings
Exempt Offerings
Offering
$2.0M
Filed
Jul 2, 2026
View

Performance

5D 20D 120D MTD YTD
CYDX -26.5% +8.0% +26.6% +82.4% +348.9%
SPY +0.1% -3.3% +2.6% -0.4% +10.4%
vs SPY -26.6% +11.2% +24.0% +82.8% +338.6%
Key facts CIK 1388994 Visit website Investor relations